Dr. Lee Yuh Shan Dr. Lee Yuh Shan
Dr. Lee Yuh Shan

Dr. Lee Yuh Shan


  • Haematology


  • English

Fellowship and Accreditation

  • MBBS (Malaya)
  • MRCP (United Kingdom)
  • FRCPath (United Kingdom)


Dr Lee Yuh Shan is a haematologist at Mount Elizabeth Hospital, Singapore. His area of expertise is in haematology such as lymphoma, myeloma and haematopoietic stem cells transplant.

Dr Lee worked for 10 years in Singapore General Hospital (SGH) and received the Singapore Health Quality Service Awards Gold and Star in 2013 and 2017. He was the director of the lymphoma service in the Department of Haematology, SGH from 2017 and lymphoma lead at SingHealth Duke Blood Cancer Centre (SDBCC) from 2018. He is active in collaborative works locally under the SDBCC and Singapore Lymphoma Working Group, as well as regionally for Chronic Lymphocytic Leukemia (CLL). Dr Lee is a member of the SingHealth Institutional Review Board (IRB) and sat on several pharmaceutical advisory boards.

Dr Lee received his basic medical degree from the University of Malaya in 2003 and membership in The Royal College of Physician (MRCP) in 2007. He completed his haematology training at SGH in 2011 and subsequently obtained his fellowship at the Royal College of Pathologists (FRCPath), UK in 2013.

Dr Lee was awarded the Health Manpower Development Plan (HMDP) in 2013 to further develop his specialty in lymphoma at the National Institutes of Health (NIH), Maryland, USA. During this period, he had the first-hand experience of seeing patients under clinical trial with new oral therapy in the treatment of chronic lymphocytic leukaemia (CLL) as well as aggressive lymphoma. Also during this period, he developed his skills in the new treatment approach for Primary Central Nervous System Lymphoma (PCNSL). After his return to Singapore, he contributed to the development and incorporation of new agents in the treatment of lymphoma, as well as to the development of investigator-initiated trials for aggressive lymphoma in the Department of Haematology, SGH.

Dr Lee has published many peer-reviewed journals and is a reviewer for one of these journals.


Latest Developments in Treating Chronic Lymphocytic Leukaemia (CLL)

Parkway Cancer Centre’s Dr Lee Yuh Shan looks at the latest developments in treating Chronic Lymphocytic Leukaemia.

Read More

Chemotherapy-free Lymphoma Treatments

Chemotherapy has been the main form of treatment for lymphoma. However, medical advancements in recent years have opened the way for targeted therapy and immunotherapy to be used more frequently in clinical practice.

Read More